COVID-19
Moderna Shares Jump on FDA's COVID-19 Vaccine Approval Framework
Moderna Inc's (NASDAQ:MRNA, ETR:0QF) shares surged by more than 6.5% on Tuesday, driven by the US Food and Drug Administration's (FDA) updated guidelines for COVID-19 vaccine approvals. The new framework maintains the status quo for the company's core market, particularly for